Germany's Drug Price Reform Brings New Opportunities and Challenges to Chinese Drugmakers as Global Peers Reassess Investment

Roche has temporarily put all future investment decisions in Germany on hold due to local healthcare cost-cutting policies, Daniel Steiner, chief executive of the Swiss…

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.yicaiglobal.com)